Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220793519> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4220793519 abstract "Abstract Purpose: Some proliferative and neoplastic changes can be seen in the endometrium of breast cancers using tamoxifen adjuvant therapy(TMX-BC). Identifying risk groups is crucial, but methods and frequency of endometrial follow-ups is still controversial. This study was aimed to investigate the clinical, ultrasonographic, and inflammatory factors to differentiate pathological endometrium in TMX-BC. Methods: This study retrospectively analyzed endometrial biopsy results of TMX-BC(n:361). Normal endometrium (Group I, n:237) and pathological endometrium(Group II, n:124) were compared for clinical, ultrasonographic, and inflammatory features. Neutrophil and platelet to lymphocyte ratio(NLR; PLR), mean platelet volume (MPV), platelet distribution width(PDW), red blood cell distribution width(RDW), and lymphocyte monocyte ratio(LMR) were the inflammatory markers. Results: The majority of TMX-BC with endometrial biopsy were asymptomatic (72.6%) and had normal endometrium (65.7%). Pathologic endometrium included endometrial polyp(31.9%), endometrial hyperplasia(1.7%), and endometrial cancer(0.8%). Duration of tamoxifen, cancer stage, vaginal bleeding, and menopause was similar in Group I and Group II (p>0.05). Group II had increased endometrial thickness (11.22±5.44mm) compared to Group I (8.51±3.43mm). Group II had higher RDW and PDW than Group I(p<0.05). Endometrial thickness ≥10 mm had significant diagnostic potential in postmenopausal women(AUC:0.676, p:0.000, CI:0.5-0.7), but not in premenopause. Conclusion: PDW and RDW may be promising markers for pathologicalendometrium differentiation, but these preliminary findings should be validated by clinical studies. Measurement of endometrial thickness in asymptomatic patients may predict high-risk women with pathologicalendometrium in postmenopausal women. Further studies are needed in premenopausal women and those using tamoxifen for more than five years." @default.
- W4220793519 created "2022-04-03" @default.
- W4220793519 creator A5043390025 @default.
- W4220793519 creator A5045619560 @default.
- W4220793519 creator A5046580116 @default.
- W4220793519 date "2022-03-15" @default.
- W4220793519 modified "2023-09-26" @default.
- W4220793519 title "The Relationship of Endometrial Pathologies with Endometrial Thickness and Inflammatory Markers in Breast Cancers Using Tamoxifen" @default.
- W4220793519 doi "https://doi.org/10.21203/rs.3.rs-1374457/v1" @default.
- W4220793519 hasPublicationYear "2022" @default.
- W4220793519 type Work @default.
- W4220793519 citedByCount "0" @default.
- W4220793519 crossrefType "posted-content" @default.
- W4220793519 hasAuthorship W4220793519A5043390025 @default.
- W4220793519 hasAuthorship W4220793519A5045619560 @default.
- W4220793519 hasAuthorship W4220793519A5046580116 @default.
- W4220793519 hasBestOaLocation W42207935191 @default.
- W4220793519 hasConcept C121608353 @default.
- W4220793519 hasConcept C126322002 @default.
- W4220793519 hasConcept C143998085 @default.
- W4220793519 hasConcept C190481736 @default.
- W4220793519 hasConcept C207886595 @default.
- W4220793519 hasConcept C2775934546 @default.
- W4220793519 hasConcept C2776606343 @default.
- W4220793519 hasConcept C2777088508 @default.
- W4220793519 hasConcept C2777176818 @default.
- W4220793519 hasConcept C2777562237 @default.
- W4220793519 hasConcept C2777689261 @default.
- W4220793519 hasConcept C2778562196 @default.
- W4220793519 hasConcept C2779742232 @default.
- W4220793519 hasConcept C29456083 @default.
- W4220793519 hasConcept C530470458 @default.
- W4220793519 hasConcept C71924100 @default.
- W4220793519 hasConcept C89560881 @default.
- W4220793519 hasConcept C90924648 @default.
- W4220793519 hasConceptScore W4220793519C121608353 @default.
- W4220793519 hasConceptScore W4220793519C126322002 @default.
- W4220793519 hasConceptScore W4220793519C143998085 @default.
- W4220793519 hasConceptScore W4220793519C190481736 @default.
- W4220793519 hasConceptScore W4220793519C207886595 @default.
- W4220793519 hasConceptScore W4220793519C2775934546 @default.
- W4220793519 hasConceptScore W4220793519C2776606343 @default.
- W4220793519 hasConceptScore W4220793519C2777088508 @default.
- W4220793519 hasConceptScore W4220793519C2777176818 @default.
- W4220793519 hasConceptScore W4220793519C2777562237 @default.
- W4220793519 hasConceptScore W4220793519C2777689261 @default.
- W4220793519 hasConceptScore W4220793519C2778562196 @default.
- W4220793519 hasConceptScore W4220793519C2779742232 @default.
- W4220793519 hasConceptScore W4220793519C29456083 @default.
- W4220793519 hasConceptScore W4220793519C530470458 @default.
- W4220793519 hasConceptScore W4220793519C71924100 @default.
- W4220793519 hasConceptScore W4220793519C89560881 @default.
- W4220793519 hasConceptScore W4220793519C90924648 @default.
- W4220793519 hasLocation W42207935191 @default.
- W4220793519 hasOpenAccess W4220793519 @default.
- W4220793519 hasPrimaryLocation W42207935191 @default.
- W4220793519 hasRelatedWork W12610511 @default.
- W4220793519 hasRelatedWork W13269569 @default.
- W4220793519 hasRelatedWork W16421040 @default.
- W4220793519 hasRelatedWork W1770501 @default.
- W4220793519 hasRelatedWork W18435423 @default.
- W4220793519 hasRelatedWork W2443436 @default.
- W4220793519 hasRelatedWork W2953784 @default.
- W4220793519 hasRelatedWork W519512 @default.
- W4220793519 hasRelatedWork W5442264 @default.
- W4220793519 hasRelatedWork W8253411 @default.
- W4220793519 isParatext "false" @default.
- W4220793519 isRetracted "false" @default.
- W4220793519 workType "article" @default.